ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

The Importance of CNS Activity in Agents for NSCLC

Alexander Drilon, MD
Published Online:5:09 PM, Fri October 20, 2017

Alexander Drilon, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the importance of central nervous system (CNS) activity in agents for the treatment of non–small cell lung cancer (NSCLC).
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.